SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -5.27%  to  Rs. 94.13 million from Rs. 99.37 millions.The Net Loss for the quarter ended June 2022 is Rs. -18.83 millions as compared to Net Profit of Rs. 16.01 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -16.15% as compared to 17.00% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 94.13 99.37 -5.27 94.13 99.37 -5.27 401.34 251.78 59.40
Other Income 0.67 0.68 -1.47 0.67 0.68 -1.47 3.06 8.02 -61.85
PBIDT -16.15 17.00 -195.00 -16.15 17.00 -195.00 14.24 -19.66 -172.43
Interest 1.99 0.47 323.40 1.99 0.47 323.40 4.01 3.89 3.08
PBDT -18.14 16.53 -209.74 -18.14 16.53 -209.74 10.23 -23.55 -143.44
Depreciation 0.69 0.52 32.69 0.69 0.52 32.69 2.76 1.76 56.82
PBT -18.83 16.01 -217.61 -18.83 16.01 -217.61 7.47 -25.31 -129.51
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -0.11 1045.45
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -0.11 1045.45
PAT -18.83 16.01 -217.61 -18.83 16.01 -217.61 8.73 -25.20 -134.64
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) -17.16 17.11 -200.29 -17.16 17.11 -200.29 3.55 -7.81 -145.44

Guj. Terce Lab Share Price

40.05 6.15 (18.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×